secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0000950170-25-063946
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q1 adjusted EPS $0.33; raises FY2025 EBITDA guidance to $220-240M
---------------------------------------------------------------------------

- Net revenue $458M, down 7% YoY due to dispositions; same-unit revenue grew 6.2% on improved payor mix and volume.
- Adjusted EBITDA $49.2M (up 32% YoY); GAAP EPS $0.24 vs $0.05; Adjusted EPS $0.33 vs $0.20.
- Raised FY2025 Adjusted EBITDA guidance to $220-240M from $215-235M after strong Q1.
- Cash from ops used $116.1M for seasonal incentive comp; total debt $611M, no revolver draw.
- Same-unit volume: NICU days +2.0%, hospital-based +1.7%, office-based +2.6% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017025063946/0000950170-25-063946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017025063946/md-20250506.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-063946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer